An Open Label, Single And Repeat Dose Randomized Crossover Study To Estimate The Pharmacokinetics And Safety Of Eletriptan Hydrobromide Tablets In Healthy Korean Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 19 Apr 2012
At a glance
- Drugs Eletriptan (Primary)
- Indications Migraine
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Pfizer
- 19 Apr 2012 Results presented at the 113th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 19 Aug 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 19 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.